Article | October 19, 2021

The Importance Of Keeping DSMBs Independent

Source: Advarra

By James Riddle, Vice President of Research Services & Strategic Consulting, and Barbara Schneider, Executive Director of Biostatistical Services

iStock-1275682432-inspection-regulatory

When conducting research, in some cases sponsors and contract research organizations (CROs) may involve a data safety monitoring board (DSMB), also referred to in regulatory documentation as a data monitoring committee (DMC). Per US Food and Drug Administration (FDA) guidance, DSMBs are supposed to be independent of the party who is conducting the research. This blog outlines when a sponsor or CRO can enlist a DSMB’s help, and why DSMB independence is critical to a successful study.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader